The PALS Study is a study for prostate cancer patients who have chosen Active Surveillance of their cancer. The goal is to learn whether weight loss, through diet and exercise, will improve the health of men with low-grade prostate cancer.
PALS will enroll about 200 overweight or obese men who plan to have a follow-up biopsy for prostate cancer. Men will be followed for 1 year. The 1-year start and end dates overlap with the prostate biopsy that is scheduled as routine care for Active Surveillance.
Study activities will take place at the Fred Hutch Cancer Research Center in Seattle. At the first visit, men will be randomly assigned to either the ‘PALS Lifestyle’ group or the ‘Comparison’ group.
Recent news coverage of the PALS study featuring one participant's success story.